Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6880)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jr GR, Canton ED, Vega ML, Greco M, Sr GR, Valsecchi ME. Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions. World J Clin Oncol 2014; 5(3): 440-454 [PMID: 25114858 DOI: 10.5306/wjco.v5.i3.440] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/440.htm |
| Number | Citing Articles |
| 1 |
Mikolaj Medon, Eva Vidacs, Stephin J Vervoort, Jason Li, Misty R. Jenkins, Kelly M. Ramsbottom, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy, Peter W. Atadja, Michael A. Henderson, Ricky W. Johnstone, Nicole M. Haynes. HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors. Cancer Research 2017; 77(10): 2594 doi: 10.1158/0008-5472.CAN-16-2247
|
| 2 |
Yigong Shi. A Glimpse of Structural Biology through X-Ray Crystallography. Cell 2014; 159(5): 995 doi: 10.1016/j.cell.2014.10.051
|
| 3 |
I A Khan, B H Yoo, O Masson, S Baron, D Corkery, G Dellaire, L D Attardi, K V Rosen. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells. Oncogene 2016; 35(44): 5759 doi: 10.1038/onc.2016.109
|
| 4 |
Mami Suzuki, Ayaka Yamanoi, Yusuke Machino, Michiko Ootsubo, Ken-ichi Izawa, Junya Kohroki, Yasuhiko Masuho. Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis. Journal of Biochemistry 2016; 159(1): 67 doi: 10.1093/jb/mvv074
|
| 5 |
Andrea Ravelli, James M Reuben, Francesco Lanza, Simone Anfossi, Maria Rosa Cappelletti, Laura Zanotti, Angela Gobbi, Manuela Milani, Daniele Spada, Paolo Pedrazzoli, Massimo Martino, Alberto Bottini, Daniele Generali. Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity. Expert Review of Anticancer Therapy 2015; 15(6): 689 doi: 10.1586/14737140.2015.1042864
|
| 6 |
Yvette W. Jeske, Shamshad Ali, Sara A Byron, Feng Gao, Robert S Mannel, Rahel G Ghebre, Paul A DiSilvestro, Shashikant B Lele, Michael L Pearl, Amy P Schmidt, Heather A Lankes, Nilsa C Ramirez, Golnar Rasty, Matthew Powell, Paul J Goodfellow, Pamela M Pollock. FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology 2017; 145(2): 366 doi: 10.1016/j.ygyno.2017.02.031
|
| 7 |
Aurélie Borrull, Bertrand Allard, Anne Wijkhuisen, Amaury Herbet, Patricia Lamourette, Wided Birouk, Denis Leiber, Zahra Tanfin, Frédéric Ducancel, Didier Boquet, Jean-Yves Couraud, Philippe Robin. Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration. mAbs 2016; 8(7): 1371 doi: 10.1080/19420862.2016.1208865
|
| 8 |
Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill Comeau, Seetharama Jois. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. International Journal of Molecular Sciences 2021; 22(2): 779 doi: 10.3390/ijms22020779
|
| 9 |
S Y Kim, J-W Theunissen, J Balibalos, S Liao-Chan, M C Babcock, T Wong, B Cairns, D Gonzalez, E H van der Horst, M Perez, Z Levashova, L Chinn, J A D‘Alessio, M Flory, A Bermudez, D Y Jackson, E Ha, J Monteon, M F Bruhns, G Chen, T-S Migone. A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer Journal 2015; 5(5): e316 doi: 10.1038/bcj.2015.39
|
| 10 |
Vassiliki Kotoula, Kalliopi Tsakiri, Georgia-Angeliki Koliou, Georgios Lazaridis, Kyriaki Papadopoulou, Eleni Giannoulatou, Ioannis Tikas, Christos Christodoulou, Kyriakos Chatzopoulos, Mattheos Bobos, George Pentheroudakis, Eleftheria Tsolaki, Anna Batistatou, Athanassios Kotsakis, Angelos Koutras, Helena Linardou, Evangelia Razis, Eleni Res, Dimitrios Pectasides, George Fountzilas. Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome. Clinical Breast Cancer 2019; 19(2): 113 doi: 10.1016/j.clbc.2018.10.014
|
| 11 |
Frederick Wang, Anne Warren Peled, Robin Chin, Barbara Fowble, Michael Alvarado, Cheryl Ewing, Laura Esserman, Robert Foster, Hani Sbitany. The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander–Implant Exchange in Prosthetic Breast Reconstruction. Plastic and Reconstructive Surgery 2016; 137(1): 1 doi: 10.1097/PRS.0000000000001866
|